Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rhythm Biosciences Limited has disclosed the initial director’s interest notice for newly appointed Director David Atkins, effective from September 30, 2024. The notice reveals Atkins holds 4 million unlisted ordinary fully paid shares, along with options for an additional 4 million shares expiring in 2026 and 2028. No interests in securities where Atkins is not the registered holder or interests in contracts were reported.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.